NCT03291145View on ClinicalTrials.gov

Exploring Mechanisms and Morphology of QT Interval Prolongation

NACompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 27, 2017

Primary Completion Date

June 27, 2018

Study Completion Date

January 1, 2019

Conditions
Long Qt Syndrome 1-2Sudden Cardiac Death
Interventions
DRUG

Beta Blockers

With and without Beta Blockers

DRUG

Spironolactone

Brisk Standing before and after seven days treatment with Spironolactone

Trial Locations (1)

2730

Herlev-Gentofte Hospital, Herlev

All Listed Sponsors
lead

Herlev and Gentofte Hospital

OTHER

NCT03291145 - Exploring Mechanisms and Morphology of QT Interval Prolongation | Biotech Hunter | Biotech Hunter